143 related articles for article (PubMed ID: 19308270)
1. Effect of Obstructive Jaundice and Nitric Oxide on the Profiles of Intestinal Bacterial Flora in Wild and iNOS Mice.
Hong JY; F Sato E; Nishikawa T; Hiramoto K; Inoue M
J Clin Biochem Nutr; 2009 Mar; 44(2):160-7. PubMed ID: 19308270
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Liver Injury during Obstructive Jaundice: Role of Nitric Oxide, Splenic Cytokines, and Intestinal Flora.
Hong JY; F Sato E; Hiramoto K; Nishikawa M; Inoue M
J Clin Biochem Nutr; 2007 May; 40(3):184-93. PubMed ID: 18398495
[TBL] [Abstract][Full Text] [Related]
3. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation.
Criado M; Flores O; Ortíz MC; Hidalgo F; Rodríguez-López AM; Eleno N; Atucha NM; Sánchez-Rodríguez A; Arévalo M; Garcia-Estañ J; López-Novoa JM
Hepatology; 1997 Aug; 26(2):268-76. PubMed ID: 9252133
[TBL] [Abstract][Full Text] [Related]
4. LPS-induced imbalanced expression of hepatic vascular stress genes in cirrhosis: possible mechanism of increased susceptibility to endotoxemia.
Baveja R; Keller S; Yokoyama Y; Sonin N; Clemens MG; Zhang JX
Shock; 2002 Apr; 17(4):316-21. PubMed ID: 11954834
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of growth hormone and insulin-like growth factor I on intestinal bacterial translocation, endotoxemia, and apoptosis in experimentally jaundiced rats.
Scopa CD; Koureleas S; Tsamandas AC; Spiliopoulou I; Alexandrides T; Filos KS; Vagianos CE
J Am Coll Surg; 2000 Apr; 190(4):423-31. PubMed ID: 10757380
[TBL] [Abstract][Full Text] [Related]
6. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells.
Arriero MM; López-Farré A; Fryeiro O; Rodríguez-Feo JA; Velasco S; García-Durán M; Fortes J; De La Pinta JC; Muñoz LE; Celdrán A
Surgery; 2001 Mar; 129(3):255-66. PubMed ID: 11231453
[TBL] [Abstract][Full Text] [Related]
7. Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated rats.
Kimmings AN; van Deventer SJ; Obertop H; Gouma DJ
J Am Coll Surg; 1999 Oct; 189(4):374-9. PubMed ID: 10509463
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human growth hormone on intestinal translocation of bacteria and endotoxin in rats with obstructive jaundice.
Yang ZW; Li JG; Mao XG; Sun B; Tong ZS; Sun HY; Li XR; Cong YP
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):445-9. PubMed ID: 16109534
[TBL] [Abstract][Full Text] [Related]
9. Expression of TLR2 and TLR5 in distal ileum of mice with obstructive jaundice and their role in intestinal mucosal injury.
Tian X; Zhang Z; Li W
Arch Med Sci; 2022; 18(1):237-250. PubMed ID: 35154543
[TBL] [Abstract][Full Text] [Related]
10. The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.
Iwasaki J; Afify M; Bleilevens C; Klinge U; Weiskirchen R; Steitz J; Vogt M; Yagi S; Nagai K; Uemoto S; Tolba RH
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035686
[TBL] [Abstract][Full Text] [Related]
11. Effects of experimental obstructive jaundice on contractile responses of dog isolated blood vessels: role of endothelium and duration of bile duct ligation.
Utkan ZN; Utkan T; Sarioglu Y; Gönüllü NN
Clin Exp Pharmacol Physiol; 2000; 27(5-6):339-44. PubMed ID: 10831233
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis.
Kawarabayashi N; Seki S; Hatsuse K; Kinoshita M; Takigawa T; Tsujimoto H; Kawabata T; Nakashima H; Shono S; Mochizuki H
Shock; 2010 May; 33(5):500-6. PubMed ID: 19823116
[TBL] [Abstract][Full Text] [Related]
13. Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase.
Knotek M; Rogachev B; Wang W; Ecder T; Melnikov V; Gengaro PE; Esson M; Edelstein CL; Dinarello CA; Schrier RW
Kidney Int; 2001 Jun; 59(6):2243-9. PubMed ID: 11380827
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane as a possible hepatotoxic factor increased by endotoxemia in obstructive jaundice.
Hanai T; Yura J; Ogino K; Hori K; Suzuki T
Jpn J Surg; 1989 Sep; 19(5):556-62. PubMed ID: 2687528
[TBL] [Abstract][Full Text] [Related]
15. Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression: beneficial effect of bombesin and neurotensin.
Assimakopoulos SF; Scopa CD; Charonis A; Spiliopoulou I; Georgiou C; Nikolopoulou V; Vagianos CE
J Am Coll Surg; 2004 May; 198(5):748-57. PubMed ID: 15110809
[TBL] [Abstract][Full Text] [Related]
16. Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; D'Amato G; Del Prete MS; Orlando F; Kamysz W; Lukasiak J; Saba V; Scalise G
Gut; 2003 Jun; 52(6):874-8. PubMed ID: 12740345
[TBL] [Abstract][Full Text] [Related]
17. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS).
Cağlikülekci M; Pata C; Apa DD; Dirlik M; Tamer L; Yaylak F; Kanik A; Aydin S
Pharmacol Res; 2004 Mar; 49(3):227-38. PubMed ID: 14726217
[TBL] [Abstract][Full Text] [Related]
18. Temporal expression of hepatic inducible nitric oxide synthase in liver cirrhosis.
Wei CL; Hon WM; Lee KH; Khoo HE
World J Gastroenterol; 2005 Jan; 11(3):362-7. PubMed ID: 15637745
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of nitric oxide in cholestasis-induced itch associated response in mice.
Ostadhadi S; Foroutan A; Momeny M; Norouzi-Javidan A; Azimi E; Kordjazy N; Dehpour AR
Biomed Pharmacother; 2016 Dec; 84():1367-1374. PubMed ID: 27802897
[TBL] [Abstract][Full Text] [Related]
20. Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences.
O'Brien A; China L; Massey KA; Nicolaou A; Winstanley A; Newson J; Hobbs A; Audzevich T; Gilroy DW
Liver Int; 2016 Jun; 36(6):837-46. PubMed ID: 26012885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
